Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
BMJ Open|January 31, 2024
Predicting response to iron supplementation in patients with active inflammatory bowel disease (PRIme): a randomised trial protocolRoberta Loveikyte, Marjolijn Duijvestein, Zlatan Mujagic, et al.Inflammatory Bowel Diseases|October 13, 2025
How Should an IBD Prevention Trial Be Designed?Rogier L Goetgebuer, Ryan C Ungaro, Brian G Feagan, et al.Schizophrenia Research|May 20, 2011
Cannabis with high cannabidiol content is associated with fewer psychotic experiencesChristian D Schubart, Iris E C Sommer, Willemijn A van Gastel, et al.Vaccines|August 23, 2020
High Immunogenicity to Influenza Vaccination in Crohn's Disease Patients Treated with UstekinumabLaura Doornekamp, Rogier L Goetgebuer, Katharina S Schmitz, et al.Alimentary Pharmacology & Therapeutics|June 9, 2026
Clinical Trial: Predicting Response to Iron Therapy in Patients With Active Inflammatory Bowel Disease Using Hepcidin and Functional Iron Indices: A Multicentre Randomised TrialLola J M Koppelman, Roberta Loveikyte, Rogier L Goetgebuer, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 16, 2023
Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory DiseasesMichelle W Cheung, Roya M Dayam, Janna R Shapiro, et al.JCI Insight|April 26, 2022
Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseasesRoya M Dayam, Jaclyn C Law, Rogier L Goetgebuer, et al.Gastrointestinal Endoscopy|March 10, 2024
Interobserver agreement of current and new proposed endoscopic scores for postoperative recurrence in Crohn's diseaseMichiel T J Bak, Nassim Hammoudi, Matthieu Allez, et al.Pageof 1